Literature DB >> 19756594

Natural killer cell is a major producer of interferon gamma that is critical for the IL-12-induced anti-tumor effect in mice.

Akio Uemura1, Tetsuo Takehara, Takuya Miyagi, Takahiro Suzuki, Tomohide Tatsumi, Kazuyoshi Ohkawa, Tatsuya Kanto, Naoki Hiramatsu, Norio Hayashi.   

Abstract

Although the anti-tumor effect of IL-12 is mediated mostly by IFNgamma, which cell types most efficiently produce IFNgamma and therefore initiate or promote the anti-tumor effect of IL-12 has not been clearly determined. In the present study, we demonstrated hydrodynamic injection of the IL-12 gene led to prolonged IFNgamma production, NK-cell activation and complete inhibition of liver metastasis of CT-26 colon cancer cells in wild-type mice, but not in IFNgamma knockout mice. NK cells expressed higher levels of STAT4 and upon IL-12 administration displayed stronger STAT4 phosphorylation and IFNgamma production than non-NK cells. Adoptive transfer of wild-type NK cells into IFNgamma knockout mice restored IL-12-induced IFNgamma production, NK-cell activation and anti-tumor effect, whereas transfer of the same number of wild-type non-NK cells did not. In conclusion, NK cells are predominant producers of IFNgamma that is critical for IL-12 anti-tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756594     DOI: 10.1007/s00262-009-0764-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  12 in total

1.  NK cell-produced IFN-γ regulates cell growth and apoptosis of colorectal cancer by regulating IL-15.

Authors:  Feng Cui; Di Qu; Ruya Sun; Mingming Zhang; Kejun Nan
Journal:  Exp Ther Med       Date:  2019-12-18       Impact factor: 2.447

Review 2.  Genomic views of STAT function in CD4+ T helper cell differentiation.

Authors:  John J O'Shea; Riitta Lahesmaa; Golnaz Vahedi; Arian Laurence; Yuka Kanno
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

3.  Transient blocking of NK cell function with small molecule inhibitors for helper dependant adenoviral vector-mediated gene delivery.

Authors:  Manjunatha Ankathatti Munegowda; Jim Hu
Journal:  Cell Biosci       Date:  2015-06-11       Impact factor: 7.133

4.  D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Authors:  Tomasz Cichoń; Ryszard Smolarczyk; Sybilla Matuszczak; Magdalena Barczyk; Magdalena Jarosz; Stanisław Szala
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-02       Impact factor: 4.291

5.  Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment.

Authors:  Kyoung-Ho Pyo; Bong-Kwang Jung; Chun-Feng Xin; You-Won Lee; Jong-Yil Chai; Eun-Hee Shin
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

Review 6.  Signal transducer and activator of transcription 4 in liver diseases.

Authors:  Yan Wang; Aijuan Qu; Hua Wang
Journal:  Int J Biol Sci       Date:  2015-02-27       Impact factor: 6.580

7.  Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of mung bean sprouts.

Authors:  Rand R Hafidh; Ahmed S Abdulamir; Fatimah Abu Bakar; Farid Azizi Jalilian; Faridah Abas; Zamberi Sekawi
Journal:  BMC Complement Altern Med       Date:  2012-11-05       Impact factor: 3.659

8.  Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy.

Authors:  Agnieszka Ciomber; Andrzej Smagur; Iwona Mitrus; Tomasz Cichoń; Ryszard Smolarczyk; Aleksander Sochanik; Stanisław Szala; Magdalena Jarosz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-13       Impact factor: 4.291

Review 9.  Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer.

Authors:  Sebastian Zundler; Markus F Neurath
Journal:  Vaccines (Basel)       Date:  2016-02-29

10.  Natural killer cells inhibit pulmonary metastasis of hepatocellular carcinoma in nude mice.

Authors:  Zai-Fa Hong; Wen-Xiu Zhao; Zhen-Yu Yin; Cheng-Rong Xie; Ya-Ping Xu; Xiao-Qin Chi; Sheng Zhang; Xiao-Min Wang
Journal:  Oncol Lett       Date:  2016-02-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.